Recent studies have shown that the use of anti-inflammatory corticosteroids (especially dexamethasone) in individuals with COVID-19 can help prevent respiratory damage and death by modifying the inflammatory injury that occurs in the lung. This research was conducted to evaluate the effect of the use of anti-inflammatory corticosteroids on the level of diabetes and kidney function in patients with COVID-19. The study was conducted at Al-Shifa Hospital for quarantine in Ramadi city on 160 patients with COVID age range (40-70 years), some of whom had diabetes and the other did not have diabetes. They were treated with corticosteroids such as dexamethasone, hydrocortisone suspension 100 mg and prednisolone, with monitoring of diabetes levels and kidney function for all patients. Results: The results showed that diabetes levels increased for some patients with a decline in kidney function, while others showed improvement in diabetes and kidney levels, and the third group was fluctuating, i.e. as the change in diabetes levels and kidney function fluctuated between the negative and positive outcomes of the patients' health condition. Conclusion: It was found that large amounts of corticosteroids used negatively affect diabetes levels and thus kidney function test, so it is necessary to conduct additional studies on the virus, especially after its recent resurgence in its mutated form, which affects all age groups of humans, is a concern.
Esraa Abd Al-Karim Marouf (Wed,) studied this question.